The 2011 Leading Life Science Intermediates Companies Financial Analyses

Date: October 22, 2010
Pages: 105
Price:
US$ 1,850.00 US$ 1,572.50
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L9319070855EN
Leaflet:

Download PDF Leaflet

The 2011 Leading Life Science Intermediates Companies Financial Analyses
Global PDF: US$ 3,900.00

Each company’s analysis provides:
  • Sales and operating profit by division, product line, geographic region and country.
  • Five-year sales and profit performance.
The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia.

Contains 105 pages and 78 tables
Skip to top


Ask Your Question

The 2011 Leading Life Science Intermediates Companies Financial Analyses
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: